Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

17.370
-0.530-2.96%
Volume:4.98M
Turnover:86.67M
Market Cap:46.19B
PE:11.72
High:17.800
Open:17.800
Low:17.180
Close:17.900
52wk High:28.232
52wk Low:14.505
Shares:2.66B
HK Float Shares:540.97M
Volume Ratio:1.02
T/O Rate:0.92%
Dividend:0.46
Dividend Rate:2.62%
EPS(LYR):1.482
ROE:7.04%
ROA:1.53%
PB:0.81
PE(LYR):11.72
PS:0.94

Loading ...

Sinopharm Group Stock Climbs 1.9% in Hong Kong

Dow Jones
·
Jul 03

Sinopharm Group Stock Rises 3.3% in Hong Kong

Dow Jones
·
Jul 02

Shanghai Junshi Biosciences HK Shares Hit 4-week Peak on Fosun's Licensing Deal

Reuters
·
Jul 02

Fosun Pharma to Offload Partnership Fund Stake for 1 Million Yuan; Shares Down 4%

MT Newswires Live
·
Jun 30

Fosun Pharma's Unit Gets Registration Nod for Spasm, Pain Drug in China

MT Newswires Live
·
Jun 29

Shanghai Fosun Pharma - Drug Registration Application for Shaoyao Gancao Tang Granules Approved by Nmpa

THOMSON REUTERS
·
Jun 29

Fosun Pharma's Subsidiary Gains Approval for Shaoyao Gancao Tang Granules

Stock News
·
Jun 29

Sinopharm Group Stock Rises 2.3% in Hong Kong

Dow Jones
·
Jun 29

Fosun Pharma's Vaccine Unit Submits Hong Kong Listing Application

MT Newswires Live
·
Jun 29

Fosun Pharma Seeks Approval to List Subsidiary Fosun Antigen on Hong Kong Main Board

Stock News
·
Jun 26

Shanghai Fosun Pharma - Co was Informed That Fosun Adgenvax Submitted Listing Application for Listing of Its H Shares on HKEX Main Board

THOMSON REUTERS
·
Jun 26

Sinopharm Group Stock Advances 1.1% in Hong Kong

Dow Jones
·
Jun 24

Sinopharm Group Stock Falls 2.7% in Hong Kong

Dow Jones
·
Jun 18

Fosun Pharma Unit Passes GMP Inspection

MT Newswires Live
·
Jun 18

Fosun Pharma Gets China Nod to Trial HLX3902 Injection

MT Newswires Live
·
Jun 18

Fosun Pharma Subsidiary Passes GMP Compliance Inspection

Stock News
·
Jun 17

Fosun Pharma Announces Final Dividend of RMB 0.39 Per Share for Payment on August 14

Stock News
·
Jun 16

Fosun Pharma Secures Shareholder Support for All AGM Proposals; Announces RMB0.39 Final Dividend

Bulletin Express
·
Jun 16

Fosun Pharma Unit's Luvometinib Gets China Nod for Langerhans Cell Histiocytosis Drug Indication

MT Newswires Live
·
Jun 16

Fosun Pharma Showcases Strategy at Abu Dhabi Forum, Highlighting Innovation and Collaboration as Key to China-UAE Healthcare Partnership

Deep News
·
Jun 15